H&F Corporate Investors X, Ltd. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001901930

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltBuy & Hold how tags are computed

Q2 2026 · 1 positions · Total reported value $2.80B · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 0.0% · 0 new · 0 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, H&F Corporate Investors X, Ltd. disclosed 1 equity positions with a combined reported value of $2.80B. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / Buy & Hold.

The largest disclosed positions as of Q2 2026 were MDLN ($2.80B). By sector, the heaviest allocations are Health Care 100.0%.

Versus the prior quarter, H&F Corporate Investors X, Ltd. opened 0 new positions, trimmed 0 and fully exited 0, a turnover rate of 0.0% of positions. The portfolio's overlap with the prior quarter was 100% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

Insider Transactions (Form 4)

Latest H&F Corporate Investors X, Ltd. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-05-28 J Medline Inc. 141,364 — SEC filing
2026-05-28 J Medline Inc. 1,536,907 — SEC filing
2026-05-28 J Medline Inc. 209,530 — SEC filing
2026-05-28 Sell Medline Inc. 1,262,726 $36.54 SEC filing
2026-05-28 Sell Medline Inc. 11,904,646 $36.54 SEC filing
2026-05-28 Sell Medline Inc. 753,528 $36.54 SEC filing
2026-05-28 Sell Medline Inc. 17,947,337 $36.54 SEC filing
2026-05-21 J Medline Inc. 18,156,867 — SEC filing

All insider transactions →

Fund Profile

H&F Corporate Investors X, Ltd. files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 1 positions worth $2.80B in total. HoldingsHub carries 5 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 1 positions · $2.80B reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: MDLN (MEDLINE INC) at 100.0%
  • Average position size: $2.80B

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 reduced

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund appears to be taking a conservative approach, possibly reflecting a cautious stance on the market or a desire to mitigate risk. The reduction in the position of MDLN suggests a preference for less volatile or more stable investments. 2. Key Moves: - Reduced: MDLN (MEDLINE INC) by 18.0% QoQ, from 86,473,497 to 70,874,326 shares. - No New Positions: The fund did not initiate any new positions in the latest quarter. 3. Portfolio Structure: - Passive/Active: The information provided does not specify if the fund is passive or active. However, the reduction in a single position suggests a more active management style, as the fund is making deliberate changes to its holdings. - Sector Bias: The fund has a significant position in the Health Care sector, as evidenced by the MDLN holding. - Risk Appetite: The reduction in the MDLN position indicates a lower risk appetite, as the fund is trimming back on potentially volatile stocks. 4. Per-Holding One-Liner: - MDLN (MEDLINE INC): A provider of online medical information services. 'Unverified' as there is no specific ETF benchmark mentioned. 5. One-Sentence Style Summary: H&F Corporate Investors X, Ltd. reduced its exposure to MDLN in Q2 2026, reflecting a cautious approach with a focus on stability and risk mitigation.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 100.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 70.87M $2.80B 100.00%
100.00%
Reduce

FAQ

What did H&F Corporate Investors X, Ltd. buy in 2026-Q2?

In its 2026-Q2 13F filing, H&F Corporate Investors X, Ltd. reported 1 equity positions worth $2.80B in aggregate; its largest disclosed positions were MDLN ($2.80B).

How large is H&F Corporate Investors X, Ltd.'s portfolio?

H&F Corporate Investors X, Ltd. reported $2.80B of long equity holdings across 1 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is H&F Corporate Investors X, Ltd.'s investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / Buy & Hold, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/h-and-f-corporate-investors-x/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →